-
With the huge potential of China's ophthalmology market, it faces three major challenges
Time of Update: 2021-12-08
This time, Shengdi Medicine's tafluprost eye drops are planned to be included in the priority review, which means that the drug is expected to be approved for marketing at an accelerated rate, thereby bringing new choices to more glaucoma patients .
-
Henan announced 25 batches of non-conforming food related to microbial pollution, food additives and other issues
Time of Update: 2020-12-26
Among them, 3 batches of samples detected acid price (in fat terms) unqualified, respectively: Yucheng County Tengbo Trading Co., Ltd. sales of the label Henan Selenium Wheat Food Co., Ltd. produced a batch of alcohol bread (original), 1 batch of alcohol bread (milk flavor); acid price mainly reflects the degree of oil acid failure in food.
-
East Sunshine will take 1.5 billion anti-thrombosis drugs
Time of Update: 2020-11-08
On October 30, the official website of the State Drug Administration showed that Dongsan pharmaceutical products to imitate the 4 categories of reported Tegrelo tablets into the administrative approval stage, is expected to be approved in recent days and treated as a review.
-
China's first chemical pharmaceutical industry brand summit will be held in Chengdu
Time of Update: 2020-06-04
Business Agency, April 12 ( Xinhua) -- China's chemical and pharmaceutical industry has achieved rapid growth in recent years, relying on huge local markets and rapid development of socio-economic l
-
The knockout stage accelerates! A large number of unrated varieties have been suspended from hanging on the net
Time of Update: 2020-05-13
Medical Network May 13 hearing more and more drug evaluation through consistency, not too large varieties comment phased out ..... Recently, Jiangsu Provincial Public Resource Exchange Center issue
-
77 products of 59 pharmaceutical factories were stopped using in Jiangxi Province, which failed to pass the consistency evaluation
Time of Update: 2019-09-17
On September 16, Jiangxi drug centralized purchase platform released the notice on adjusting the online purchase qualification of clindamycin and other drugs According to the 2015 implementation plan
-
The second batch of 40 varieties purchased with national capacity has been selected
Time of Update: 2019-02-20
The second batch of national procurement with volume, or the plan issued in June, implemented in October! ▍ more than 40 varieties have been selected, or a few days ago, there was news in the industry
-
[heavyweight] review of cGMP review in the middle of the year: Why did Pfizer and Bayer receive FDA warning? The launch of Tyva heavyweight migraine drug was delayed
Time of Update: 2018-08-06
In 2018 cGMP review, global enterprises are facing severe inspection "storm" In the past, data integrity and deviation were the main concerns of inspectors This year, inspectors pay more attention to
-
Summary of major events in April
Time of Update: 2016-05-09
In April, the State Council, the national health and Family Planning Commission, the Ministry of human resources and social security, the Ministry of finance, CFDA and other departments issued policie
-
Children's traditional Chinese medicine is exposed to the problem of drug use
Time of Update: 2013-07-05
"In the near future, children's traditional Chinese medicine will be an indispensable main force in the traditional Chinese medicine industry More than 500 million strategic products will be produced
